ULTRAGENYX PHARMACEUTICAL INC. Other Comprehensive Income (Loss), Net of Tax
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Other Comprehensive Income (Loss), Net of Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-05
- ULTRAGENYX PHARMACEUTICAL INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $0.00.
- ULTRAGENYX PHARMACEUTICAL INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$1.00M, a 200.00% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $537.00K.
- ULTRAGENYX PHARMACEUTICAL INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $1.09M, a 45.35% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. other comprehensive income (loss), net of tax for fiscal 2025 was $2.00M.
- ULTRAGENYX PHARMACEUTICAL INC. other comprehensive income (loss), net of tax for fiscal 2024 was -$2.00M, a 125.00% decline from fiscal 2023.
- ULTRAGENYX PHARMACEUTICAL INC. other comprehensive income (loss), net of tax for fiscal 2023 was $8.00M.
- ULTRAGENYX PHARMACEUTICAL INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$5.17M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | -$1.00M 10-Q · filed 2026-08-05 | -$463.00K derived: sum of 3 quarters · filed 2026-08-05 | $625.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | -$1.00M 10-Q · filed 2026-05-06 | -$463.00K derived: sum of 2 quarters · filed 2026-05-06 | $625.00K derived: sum of 3 quarters · filed 2026-05-06 | $625.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $537.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $1.63M derived: sum of 2 quarters · filed 2026-02-18 | $1.63M derived: sum of 3 quarters · filed 2026-08-05 | $2.00M 10-K · filed 2026-02-18 | |||
| 2025-09-30 | $1.09M 10-Q · filed 2025-11-05 | $1.09M derived: sum of 2 quarters · filed 2026-08-05 | $1.46M 10-Q · filed 2025-11-05 | -$161.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 | $73.00K 10-Q · filed 2025-08-06 | $1.00M 10-Q · filed 2026-08-05 | $375.00K 10-Q · filed 2025-08-06 | -$1.25M derived: sum of 3 quarters · filed 2026-08-05 | $742.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $1.00M 10-Q · filed 2026-05-06 | $302.00K 10-Q · filed 2025-05-07 | -$1.25M derived: sum of 2 quarters · filed 2026-05-06 | $742.00K derived: sum of 3 quarters · filed 2026-05-06 | $78.00K derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$258.00K derived: sum of 2 quarters · filed 2026-02-18 | -$922.00K derived: sum of 3 quarters · filed 2026-02-18 | -$2.00M 10-K · filed 2026-02-18 | -$1.29M 10-K · filed 2025-02-19 | ||
| 2024-09-30 | $1.99M 10-Q · filed 2025-11-05 | $1.33M derived: sum of 2 quarters · filed 2025-11-05 | $249.00K 10-Q · filed 2025-11-05 | $3.92M derived: sum of 4 quarters · filed 2026-02-18 | |||
| 2024-06-30 | -$664.00K 10-Q · filed 2025-08-06 | -$1.74M 10-Q · filed 2025-08-06 | $1.93M derived: sum of 3 quarters · filed 2026-02-18 | $2.78M derived: sum of 4 quarters · filed 2026-02-18 | |||
| 2024-03-31 | -$1.08M 10-Q · filed 2025-05-07 | $2.59M derived: sum of 2 quarters · filed 2026-02-18 | $3.45M derived: sum of 3 quarters · filed 2026-02-18 | $4.32M derived: sum of 4 quarters · filed 2026-02-18 | |||
| 2023-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $4.53M derived: sum of 2 quarters · filed 2026-02-18 | $5.39M derived: sum of 3 quarters · filed 2026-02-18 | $8.00M 10-K · filed 2026-02-18 | $7.22M 10-K · filed 2024-02-21 | ||
| 2023-09-30 | $854.00K 10-Q · filed 2024-11-06 | $1.72M derived: sum of 2 quarters · filed 2024-11-06 | $4.33M 10-Q · filed 2024-11-06 | $7.98M derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-06-30 | $869.00K 10-Q · filed 2024-08-02 | $3.48M 10-Q · filed 2024-08-02 | $7.12M derived: sum of 3 quarters · filed 2025-02-19 | $5.82M derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-03-31 | $2.61M 10-Q · filed 2024-05-03 | $6.25M derived: sum of 2 quarters · filed 2025-02-19 | $4.95M derived: sum of 3 quarters · filed 2025-02-19 | $2.59M derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2022-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $2.34M derived: sum of 2 quarters · filed 2025-02-19 | -$19.00K derived: sum of 3 quarters · filed 2025-02-19 | -$5.17M 10-K · filed 2025-02-19 | |||
| 2022-09-30 | -$1.31M 10-Q · filed 2023-11-03 | -$3.67M derived: sum of 2 quarters · filed 2023-11-03 | -$8.82M 10-Q · filed 2023-11-03 | -$10.28M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | -$2.36M 10-Q · filed 2023-08-04 | -$7.51M 10-Q · filed 2023-08-04 | -$8.97M derived: sum of 3 quarters · filed 2024-02-21 | -$9.15M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | -$5.15M 10-Q · filed 2023-05-05 | -$6.61M derived: sum of 2 quarters · filed 2024-02-21 | -$6.79M derived: sum of 3 quarters · filed 2024-02-21 | -$6.61M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$1.64M derived: sum of 2 quarters · filed 2024-02-21 | -$1.46M derived: sum of 3 quarters · filed 2024-02-21 | -$2.09M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | -$178.00K 10-Q · filed 2022-11-03 | -$2.00K derived: sum of 2 quarters · filed 2022-11-03 | -$635.00K 10-Q · filed 2022-11-03 | -$959.00K derived: sum of 4 quarters · filed 2023-02-17 | |||
| 2021-06-30 | $176.00K 10-Q · filed 2022-07-29 | -$457.00K 10-Q · filed 2022-07-29 | -$781.00K derived: sum of 3 quarters · filed 2023-02-17 | -$1.05M derived: sum of 4 quarters · filed 2023-02-17 | |||
| 2021-03-31 | -$633.00K 10-Q · filed 2022-05-06 | -$957.00K derived: sum of 2 quarters · filed 2023-02-17 | -$1.23M derived: sum of 3 quarters · filed 2023-02-17 | $1.60M derived: sum of 4 quarters · filed 2023-02-17 | |||
| 2020-12-31 | -$324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | -$595.00K derived: sum of 2 quarters · filed 2023-02-17 | $2.23M derived: sum of 3 quarters · filed 2023-02-17 | $836.00K 10-K · filed 2023-02-17 | |||
| 2020-09-30 | -$271.00K 10-Q · filed 2021-11-03 | $2.56M derived: sum of 2 quarters · filed 2021-11-03 | $1.16M 10-Q · filed 2021-11-03 | $1.08M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-06-30 | $2.83M 10-Q · filed 2021-08-03 | $1.43M 10-Q · filed 2021-08-03 | $1.35M derived: sum of 3 quarters · filed 2022-02-15 | $1.03M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-03-31 | -$1.40M 10-Q · filed 2021-05-05 | -$1.47M derived: sum of 2 quarters · filed 2022-02-15 | -$1.80M derived: sum of 3 quarters · filed 2022-02-15 | -$1.40M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2019-12-31 | -$76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$402.00K derived: sum of 2 quarters · filed 2022-02-15 | $1.00K derived: sum of 3 quarters · filed 2022-02-15 | $486.00K 10-K · filed 2022-02-15 | |||
| 2019-09-30 | -$326.00K 10-Q · filed 2020-10-27 | $77.00K derived: sum of 2 quarters · filed 2020-10-27 | $562.00K 10-Q · filed 2020-10-27 | $339.00K derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2019-06-30 | $403.00K 10-Q · filed 2020-07-30 | $888.00K 10-Q · filed 2020-07-30 | $665.00K derived: sum of 3 quarters · filed 2021-02-12 | $909.00K derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2019-03-31 | $485.00K 10-Q · filed 2020-05-07 | $262.00K derived: sum of 2 quarters · filed 2021-02-12 | $506.00K derived: sum of 3 quarters · filed 2021-02-12 | $798.00K derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2018-12-31 | -$223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $21.00K derived: sum of 2 quarters · filed 2021-02-12 | $313.00K derived: sum of 3 quarters · filed 2021-02-12 | $5.05M 10-K · filed 2021-02-12 | |||
| 2018-09-30 | $244.00K 10-Q · filed 2019-11-06 | $536.00K derived: sum of 2 quarters · filed 2019-11-06 | $5.27M 10-Q · filed 2019-11-06 | $6.99M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2018-06-30 | $292.00K 10-Q · filed 2019-08-02 | $5.03M 10-Q · filed 2019-08-02 | $6.75M derived: sum of 3 quarters · filed 2020-02-14 | $3.57M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2018-03-31 | $4.73M 10-Q · filed 2019-05-07 | $6.46M derived: sum of 2 quarters · filed 2020-02-14 | $3.28M derived: sum of 3 quarters · filed 2020-02-14 | -$1.18M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2017-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$1.46M derived: sum of 2 quarters · filed 2020-02-14 | -$5.91M derived: sum of 3 quarters · filed 2020-02-14 | -$6.58M 10-K · filed 2020-02-14 | |||
| 2017-09-30 | -$3.18M 10-Q · filed 2018-11-06 | -$7.63M derived: sum of 2 quarters · filed 2018-11-06 | -$8.31M 10-Q · filed 2018-11-06 | -$7.42M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-06-30 | -$4.45M 10-Q · filed 2018-08-03 | -$5.13M 10-Q · filed 2018-08-03 | -$4.24M derived: sum of 3 quarters · filed 2019-02-20 | -$4.47M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-03-31 | -$674.00K 10-Q · filed 2018-05-08 | $219.00K derived: sum of 2 quarters · filed 2019-02-20 | -$21.00K derived: sum of 3 quarters · filed 2019-02-20 | $139.00K derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2016-12-31 | $893.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $653.00K derived: sum of 2 quarters · filed 2019-02-20 | $813.00K derived: sum of 3 quarters · filed 2019-02-20 | $1.77M 10-K · filed 2019-02-20 | |||
| 2016-09-30 | -$240.00K 10-Q · filed 2017-11-03 | -$80.00K derived: sum of 2 quarters · filed 2017-11-03 | $880.00K 10-Q · filed 2017-11-03 | $51.00K derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-06-30 | $160.00K 10-Q · filed 2017-07-28 | $1.12M 10-Q · filed 2017-07-28 | $291.00K derived: sum of 3 quarters · filed 2018-02-21 | $461.00K derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-03-31 | $960.00K 10-Q · filed 2017-05-05 | $131.00K derived: sum of 2 quarters · filed 2018-02-21 | $301.00K derived: sum of 3 quarters · filed 2018-02-21 | $186.00K derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2015-12-31 | -$829.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$659.00K derived: sum of 2 quarters · filed 2018-02-21 | -$774.00K derived: sum of 3 quarters · filed 2018-02-21 | -$694.00K 10-K · filed 2018-02-21 | |||
| 2015-09-30 | $170.00K 10-Q · filed 2016-11-08 | $55.00K derived: sum of 2 quarters · filed 2016-11-08 | $135.00K 10-Q · filed 2016-11-08 | ||||
| 2015-06-30 | -$115.00K 10-Q · filed 2016-08-09 | -$35.00K 10-Q · filed 2016-08-09 | |||||
| 2014-12-31 | -$185.00K 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |